Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 30, 2011, Pages 12425-12430

  Jinushi, Masahisa ^a   Chiba, Shigeki ^a   Yoshiyama, Hironori ^a   Masutomi, Kenkichi ^b   Kinoshita, Ichiro ^c   Dosaka Akita, Hirotoshi ^c   Yagita, Hideo ^d   Takaoka, Akinori ^a   Tahara, Hideaki ^e  

^a HOKKAIDO UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

Chemoresistance; Tumor progression

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; INTERLEUKIN 6; LACTADHERIN; SONIC HEDGEHOG PROTEIN; STAT3 PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CELL; CANCER RESISTANCE; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; GENE EXPRESSION; HUMAN; HUMAN CELL; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; TUMOR MICROENVIRONMENT;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, SURFACE; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; HEDGEHOG PROTEINS; HUMANS; INTERLEUKIN-6; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; MILK PROTEINS; MODELS, IMMUNOLOGICAL; NEOPLASMS; NEOPLASTIC STEM CELLS; RNA, MESSENGER; RNA, NEOPLASM; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TUMOR MICROENVIRONMENT;

ERINACEIDAE;

EID: 79961074770     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1106645108     Document Type: Article

References (38)

1. Jänne PA, Engelman JA, Johnson BE (2005) Epidermal growth factor receptor mutations in non-small-cell lung cancer: Implications for treatment and tumor biology. J Clin Oncol 23:3227-3234. (Pubitemid 46211347)
2. Esteller M, et al. (2000) Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343:1350-1354.
3. Higgins CF (2007) Multiple molecular mechanisms for multidrug resistance transporters. Nature 446:749-757.
4. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414:105-111. (Pubitemid 33041634)
5. Condeelis J, Pollard JW (2006) Macrophages: Obligate partners for tumor cell migration, invasion, and metastasis. Cell 124:263-266. (Pubitemid 43121975)
6. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867. (Pubitemid 36019639)
7. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140:883-899.
8. Hanayama R, et al. (2002) Identification of a factor that links apoptotic cells to phagocytes. Nature 417:182-187. (Pubitemid 34506799)
9. Jinushi M, et al. (2007) MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF. J Clin Invest 117:1902-1913. (Pubitemid 47036324)
10. Jinushi M, et al. (2009) Milk fat globule epidermal growth factor-8 blockade triggers tumor destruction through coordinated cell-autonomous and immune-mediated mechanisms. J Exp Med 206:1317-1326.
11. Jinushi M, et al. (2008) Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res 68:8889-8898.
12. Kranich J, et al. (2008) Follicular dendritic cells control engulfment of apoptotic bodies by secreting Mfge8. J Exp Med 205:1293-1302. (Pubitemid 351831487)
13. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988. (Pubitemid 36418143)
14. O'Brien CA, Pollett A, Gallinger S, Dick JE (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110. (Pubitemid 46067310)
15. Schatton T, et al. (2008) Identification of cells initiating human melanomas. Nature 451:345-349.
16. Ginestier C, et al. (2007) ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567. (Pubitemid 350056407)
17. Eramo A, Haas TL, De Maria R (2010) Lung cancer stem cells: Tools and targets to fight lung cancer. Oncogene 29:4625-4635.
18. Mantovani A, Sica A (2010) Macrophages, innate immunity and cancer: Balance, tolerance, and diversity. Curr Opin Immunol 22:231-237.
19. Doedens AL, et al. (2010) Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression. Cancer Res 70:7465-7475.
20. Zabuawala T, et al. (2010) An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. Cancer Res 70:1323-1333.
21. Hagemann T, et al. (2006) Ovarian cancer cells polarize macrophages towards a tumor-associated phenotype. J Immunol 176:5023-5032.
22. Lewis CE, De Palma M, Naldini L (2007) Tie2-expressing monocytes and tumor angiogenesis: Regulation by hypoxia and angiopoietin-2. Cancer Res 67:8429-8432. (Pubitemid 47437413)
23. Sugano G, et al. (2011) Milk fat globule-epidermal growth factor-factor VIII (MFGE8)/lactadherin promotes bladder tumor development. Oncogene 30:642-653.
24. Guan Y, Gerhard B, Hogge DE (2003) Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 101:3142-3149. (Pubitemid 36858008)
25. Clarke MF, et al. (2006) Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 66:9339-9344.
26. Arai F, et al. (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell 118:149-161. (Pubitemid 38962572)
27. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer 9:798-809.
28. Naugler WE, et al. (2007) Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317:121-124. (Pubitemid 47056470)
29. Iliopoulos D, Hirsch HA, Struhl K (2009) An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139: 693-706.
30. Quintana E, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456:593-598.
31. Hanayama R, et al. (2004) Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 304:1147-1150. (Pubitemid 38661849)
32. Kim S, et al. (2009) Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457:102-106.
33. Aspord C, et al. (2007) Breast cancer instructs dendritic cells to prime interleukin 13- secreting CD4+ T cells that facilitate tumor development. J Exp Med 204:1037-1047. (Pubitemid 46798148)
34. Naka K, et al. (2010) TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature 463:676-680.
35. Zhou J, et al. (2007) Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci USA 104: 16158-16163. (Pubitemid 350099378)
36. Yang J, et al. (2010) Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell 7:319-328.
37. Zhao C, et al. (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776-779.
38. Gupta PB, et al. (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645-659.